[Bionime Corporation] 2026 Q1 EPS -1.09 NTD
Key facts
- [Bionime Corporation] 2026 Q1 EPS -1.09 NTD
- Bionime Corporation reported its Q1 2026 financial results, posting an EPS of -1.09 NTD and a net loss of 79 million NTD.
- Source: PR Times
- Date: March 1, 2026
Direct answer
Bionime Corporation reported its Q1 2026 financial results, posting an EPS of -1.09 NTD and a net loss of 79 million NTD.
- Citation
- [Bionime Corporation] 2026 Q1 EPS -1.09 NTD (March 1, 2026), PR Times
- Source
- PR Times
- Date
- March 1, 2026
Bionime Corporation reported its Q1 2026 financial results, posting an EPS of -1.09 NTD and a net loss of 79 million NTD.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: May 15, 2026 at 08:01 (1799h 1m after Published)
- 🤖 AI Analyzed: May 15, 2026 at 18:34 (10h 32m after Collected)
Company Code: 4737
Company Name: Bionime Corporation
Industry: Biotech & Medical
Year/Quarter: 2026 Q1
Basic EPS: -1.09 NTD
Operating Revenue: 0.405 billion NTD
Net Income after Tax: -0.079 billion NTD
Company Name: Bionime Corporation
Industry: Biotech & Medical
Year/Quarter: 2026 Q1
Basic EPS: -1.09 NTD
Operating Revenue: 0.405 billion NTD
Net Income after Tax: -0.079 billion NTD
FAQ
What are the key facts in this article?
Bionime Corporation reported its Q1 2026 financial results, posting an EPS of -1.09 NTD and a net loss of 79 million NTD.
What is the direct answer?
Bionime Corporation reported its Q1 2026 financial results, posting an EPS of -1.09 NTD and a net loss of 79 million NTD.
What is the source and date?
PR Times: https://openapi.twse.com.tw/financial/twse-fin-4737-2026Q1 | March 1, 2026